The Efficacy of MK-8291 in Participants With Post-herpetic Neuralgia (PHN) With Allodynia (MK-8291-012)
Status:
Completed
Trial end date:
2016-02-29
Target enrollment:
Participant gender:
Summary
This study aims to determine whether MK-8291 is effective in reducing pain in participants
with post-herpetic neuralgia (PHN) with allodynia.
The primary hypothesis is that when compared to placebo, treatment with MK-8291 reduces the
change from Baseline in participant-reported pain intensity by 1 on an 11-point numeric
rating scale.